Table.
Summary of results
| Patients n | Female/male n (%) | Age mean±SD (min–max) | BMI mean±SD (min–max) | SMA type (1/2/3), n | Injection n (%) | Level n (%) | Needle size n (%) | Needle length n (%) | Anesthesia n (%) | Radiation | Complication, n | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CT-TFLP | 13 | 9 (69.2) /4 (30.8) | 35.4±7 (23–51) | 21.9±5.8 (12.6–30.8) | 0/12/1 | 65 (24.5) | L2–L3: 23 (35.3) L3–L4: 34 (52.3) L4–L5: 8 (6.4) |
22 G: 64 (98) 25G: 1 (2) |
3.5″: 24 (40.6) 5″: 32 (54.2) 7″: 3 (5.2) |
All local | Total DLP (mGy·cm) Mean 52.1 (22–158) |
PLPH >1 day: 1 PLPH spontaneous resolution: 7 Hot flashes: 1 Radicular pain: 2 Soreness: 2 |
| FGLP | 24 | 9 (37.5) /15 (62.5) | 28.7±17.2 (15–62) | 24.5±8.9 (10.9–39.7) | 1/11/12 | 106 (40) | L1–L2:1 (0.9) L2–L3: 23 (21.7) L3–L4: 16 (15) L4–L5: 26 (24.5) L5-S1:26 (24.5) S1–S2:14 (13.2) |
22 G: 102 (96.2) 25 G: 4 (3.8) |
1.5″: 1 (0.9) 3.5″: 78 (73.6) 5″: 25 (23.6) 7″: 2 (1.9) |
Local: 101 (96) Moderate: 2 (2) General anesthesia: 3 (2) |
Fluoroscopy time (min) Median: 0.5 (0.1–7.2) |
PLPH > 1 day: 4 PLPH spontaneous resolution: 3 Soreness: 2 |
| Conventional LP | 16 | 7 (43.7) /9 (54.3) | 12±17.1 (<1–52) | 19.4±7 (13.5–38.1) | 3/8/5 | 83 (31.3) | L2–L3: 5 (6) L3–L4: 66 (79.5) L4–L5: 12 (14.5) |
All 22 G | 1.5″: 48 (57.8) 3.5″: 34 (40.9) 5″: 1 (1.3) |
Local: 29 (35) Moderate: 23 (28) General anesthesia: 20 (24) Unknown: 11 (13) |
NA | PLPH >1 day: 1 PLPH spontaneous resolution: 3 Soreness: 2 |
| Reservoir | 3 | 1 (33.4) /2 (66.6) | 23.3±10.5 (13–34) | 28.3±4.5 (23.2–31.9) | 0/1/2 | 11 (4.2) | 1 lumbar 2 cranial |
NA | NA | All local | NA | Reservoir infection: 1 Vagal syncope: 1 Headache with spontaneous resolution: 1 |
| Total | 52 | 24 (46.2) /28 (53.8) | 25.5±17 (<1–62) | 22.2±7.3 (10.9–39.7) | 4 /30 /18 | 265 | Local: 206 (77.9) Moderate: 25 (9.4) General anesthesia: 23 (8.6) Unknown: 11 (4.1) |
NA | PLPH >1 day: 6 PLPH spontaneous resolution: 14 Soreness: 6 Radicular pain: 2 Hot flashes: 1 Vagal syncope: 1 |
BMI, body mass index; SMA, spinal muscular atrophy; CT-TFLP, computed tomography-guided transforaminal lumbar puncture; DLP, dose length product; PLPH, post-lumbar puncture headache; FLGP, fluoroscopy-guided lumbar puncture; NA, not available.